Clinical Trial Update: Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta [Phase 1]

View source ↗

Summary

This Phase 1 trial seeks to optimize lymphodepletion strategies to improve outcomes for patients with diffuse large B-cell lymphoma receiving the Yescarta CAR-T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Yescarta (axicabtagene ciloleucel)

Snippet

Sponsor: University Health Network, Toronto | Conditions: DLBCL - Diffuse Large B Cell Lymphoma | Phase 1 | Status: RECRUITING